- Home
- ESOA vs IPHA Comparison
ESOA vs IPHA Comparison
Compare ESOA & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESOA
- IPHA
- Stock Information
- Founded
- ESOA 2006
- IPHA 1999
- Country
- ESOA United States
- IPHA France
- Employees
- ESOA N/A
- IPHA N/A
- Industry
- ESOA Water Sewer Pipeline Comm & Power Line Construction
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- ESOA Industrials
- IPHA Health Care
- Exchange
- ESOA Nasdaq
- IPHA Nasdaq
- Market Cap
- ESOA 180.0M
- IPHA 160.1M
- IPO Year
- ESOA 2006
- IPHA 2019
- Fundamental
- Price
- ESOA $10.62
- IPHA $1.79
- Analyst Decision
- ESOA Strong Buy
- IPHA Strong Buy
- Analyst Count
- ESOA 1
- IPHA 3
- Target Price
- ESOA $21.00
- IPHA $5.00
- AVG Volume (30 Days)
- ESOA 130.7K
- IPHA 27.1K
- Earning Date
- ESOA 12-15-2025
- IPHA 09-17-2025
- Dividend Yield
- ESOA 1.12%
- IPHA N/A
- EPS Growth
- ESOA N/A
- IPHA N/A
- EPS
- ESOA 0.17
- IPHA N/A
- Revenue
- ESOA $385,589,109.00
- IPHA $14,839,695.00
- Revenue This Year
- ESOA $13.08
- IPHA $22.29
- Revenue Next Year
- ESOA $3.54
- IPHA $43.84
- P/E Ratio
- ESOA $63.66
- IPHA N/A
- Revenue Growth
- ESOA 9.52
- IPHA N/A
- 52 Week Low
- ESOA $7.64
- IPHA $1.29
- 52 Week High
- ESOA $19.83
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- ESOA 50.79
- IPHA 36.43
- Support Level
- ESOA $10.59
- IPHA $1.95
- Resistance Level
- ESOA $11.50
- IPHA $2.40
- Average True Range (ATR)
- ESOA 0.58
- IPHA 0.11
- MACD
- ESOA -0.01
- IPHA -0.04
- Stochastic Oscillator
- ESOA 34.09
- IPHA 6.15
About ESOA Energy Services of America Corporation
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.